Combined inhibition of tumor suppressors PTEN and PP2A drives anoikis resistance and is associated with therapy relapse in prostate cancer




Rupp C, Isomursu A, Aakula A, Erickson A, Li SP, Kaur A, Shah P, Pokharel YR, Trottman L, Lammerding J, Rannikko A, Taimen P, Mirtti T, Paatero I, Ivaska J, Westermarck JK

American Association for Cancer Research Annual Meeting 2019

PublisherAMER ASSOC CANCER RESEARCH

2019

Cancer Research

CANCER RESEARCH

CANCER RES

3486

79

13 Suppl.

3486

2

0008-5472

DOIhttps://doi.org/10.1158/1538-7445.SABCS18-3486




Last updated on 2024-26-11 at 22:13